综述

超级增强子在肿瘤研究中的进展

展开
  • 1. 天津医科大学肿瘤医院,放射治疗科,天津 300060
    2. 国家肿瘤临床医学研究中心,天津市“肿瘤防治”重点实验室,天津市恶性肿瘤临床医学研究中心,天津 300060;
    3. 天津医科大学基础医学院,生物化学与分子生物学系,天津 300070
吴志强,博士,讲师,研究方向:放射生物学,肿瘤分子生物学。E-mail: zwu08@tmu.edu.cn

收稿日期: 2018-07-13

  修回日期: 2018-09-21

  网络出版日期: 2018-11-06

基金资助

国家自然科学基金项目(编号:81502660,31700144)和天津市自然科学基金项目(编号:16JCQNJC10000, 17JCQNJC10600)资助

Research progress of super enhancer in cancer

Expand
  • 1. Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China;
    2. Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
    3. Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Tianjin Medical University, Tianjin 300070, China

Received date: 2018-07-13

  Revised date: 2018-09-21

  Online published: 2018-11-06

Supported by

[Supported by the National Natural Science Foundation of China (Nos. 81502660,31700144) and Tianjin Municipal Science and Technology Commission (Nos. 16JCQNJC10000, 17JCQNJC10600)]

摘要

超级增强子是由多个相邻近的普通增强子组成的、驱动调控细胞身份基因表达的一个大簇,该区域富集高密度的转录因子、辅因子及增强子相关表观修饰。超级增强子所驱动的异常转录基因对维持肿瘤细胞特性至关重要。肿瘤细胞通过组装自身超级增强子,显著促进多种癌基因表达,从而增强肿瘤细胞的增殖、侵袭和转移的能力;抑制超级增强子的活性,则显著抑制肿瘤细胞的生长和存活。本文对目前报道的肿瘤细胞中超级增强子的结构特征和功能调控,以及靶向超级增强子药物研发现状进行了总结,旨在为研发新的针对超级增强子为靶点的抗肿瘤药物提供理论基础和借鉴。

本文引用格式

吴志强, 米泽云 . 超级增强子在肿瘤研究中的进展[J]. 遗传, 2019 , 41(1) : 41 -51 . DOI: 10.16288/j.yczz.18-152

Abstract

Super enhancers (SEs) are composed of clusters of enhancers in close genomic proximity. They constitute a large family of regulatory elements that specify gene expression patterns and cell identity. SE regions consist of unusually strong enrichment of binding sites for transcriptional factors, cofactors, and enhancers associated with epigenetic modifications. SEs play important roles in regulating the aberrant gene expression in tumor cells. Via SEs, cancer cells activate the expression of various oncogenes, and promote cell proliferation, invasion and migration properties. Hence suppression of SEs activities could inhibit the growth and survival of cancer cells. In this review, we summarize the fundamental principles, functions and regulation of super enhancers and therapeutic potential in targeting SEs in cancer cells, thereby introducing and providing new conceptions for development of antineoplastic drugs.

参考文献

[1] Banerji J, Rusconi S, Schaffner W . Expression of a beta- globin gene is enhanced by remote SV40 DNA sequences. Cell, 1981,27(2 Pt 1):299-308. [DOI]
[2] Blackwood EM, Kadonaga JT . Going the distance: a current view of enhancer action. Science, 1998,281(5373):60-63. [DOI]
[3] Bulger M, Groudine M . Functional and mechanistic diversity of distal transcription enhancers. Cell, 2011,144(3):327-339. [DOI]
[4] Sun CB, Zhang X . Advance in the research on super- enhancer. Hereditas(Beijing), 2016,38(12):1056-1068.
[4] 孙长斌, 张曦 . 超级增强子研究进展. 遗传, 2016,38(12):1056-1068. [DOI]
[5] Levine M . Transcriptional enhancers in animal development and evolution. Curr Biol, 2010,20(17):R754-763. [DOI]
[6] Sengupta S, George RE . Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer, 2017,3(4):269-281. [DOI]
[7] Ing-Simmons E, Seitan VC, Faure AJ, Flicek P, Carroll T, Dekker J, Fisher AG, Lenhard B, Merkenschlager M . Spatial enhancer clustering and regulation of enhancer- proximal genes by cohesin. Genome Res, 2015,25(4):504-513. [DOI]
[8] Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA . Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 2013,153(2):307-319. [DOI]
[9] Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA . Super-enhancers in the control of cell identity and disease. Cell, 2013,155(4):934-947. [DOI]
[10] Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, Chipumuro E, Herter-Sprie GS, Akbay EA, Altabef A, Zhang J, Shimamura T, Capelletti M, Reibel JB, Cavanaugh JD, Gao P, Liu Y, Michaelsen SR, Poulsen HS, Aref AR, Barbie DA, Bradner JE, George RE, Gray NS, Young RA, Wong KK . Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell, 2014,26(6):909-922. [DOI]
[11] Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA . Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell, 2015,58(2):362-370. [DOI]
[12] Saint-André V, Federation AJ, Lin CY, Abraham BJ, Reddy J, Lee TI, Bradner JE, Young RA . Models of human core transcriptional regulatory circuitries. Genome Res, 2016,26(3):385-396. [DOI]
[13] Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, Wick MJ, El-Naggar AK, Bradner JE, Moskaluk CA, Aster JC, Knoechel B, Bernstein BE . An oncogenic MYB feedback loop drives alternate cell fates in adenoid cysti
文章导航

/